NuGen Medical Devices Inc.
NGMD.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.67M | -1.58M | -2.40M | -1.41M | -3.85M |
| Total Depreciation and Amortization | 494.80K | 464.30K | 455.20K | 453.60K | 471.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.78M | -1.09M | -979.20K | -1.76M | 178.70K |
| Change in Net Operating Assets | -156.80K | -1.63M | -814.00K | -661.50K | -205.80K |
| Cash from Operations | -2.55M | -3.84M | -3.73M | -3.38M | -3.41M |
| Capital Expenditure | -217.80K | -100.40K | -45.70K | -7.40K | -7.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.00K | -1.10K | -600.00 | -900.00 | -1.20K |
| Cash from Investing | -218.80K | -101.50K | -46.30K | -8.30K | -8.60K |
| Total Debt Issued | -- | 0.00 | 10.00M | 10.00M | 10.00M |
| Total Debt Repaid | -- | 0.00 | 0.00 | -7.00K | -27.80K |
| Issuance of Common Stock | 60.50K | 465.50K | 530.50K | 530.50K | 1.24M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 42.20K | 331.50K | 7.71M | 7.71M | 8.22M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.73M | -3.61M | 3.93M | 4.32M | 4.80M |